Symbol
Name
ID
|
|
|
Synonyms
|
C3DR, CD21, CD35, Cr-1, Cr-2, Cr1
|
|
Genetic Map
|
|
|
Sequence Map
|
|
Mammalian
homology
|
|
|
Sequences
|
All sequences(28)
|
Alleles
and
phenotypes
|
All alleles(5) :
Targeted, knock-out(4)
Targeted, other(1)
| Homozygotes for targeted null mutations exhibit impaired humoral immune responses to T cell-dependent antigens, with limited affinity maturation, and reduced memory B cell and germinal center formation. |
|
|
Polymorphisms
|
All PCR and RFLP(3) :
PCR(1)
RFLP(2)
SNPs within 2kb(153 from dbSNP Build 128)
|
Gene Ontology
(GO)
classifications
|
|
|
Expression
|
Literature Summary: (3 records)
Data Summary:
Assays (1)
Results (42)
Tissues (31)
Theiler Stages: 16,18,20,21,23,25,28
| |
Assay Type |
Assays |
|
Results |
| |
RT-PCR |
1 |
|
42 |
cDNA source data(35)
External Resources:
Allen Brain Atlas
GEO
ArrayExpress
|
Molecular
reagents
|
All nucleic(51)
Genomic(12)
cDNA(36)
Primer pair(2)
Other(1)
Microarray probesets(2)
|
Other database
links
|
|
Protein
domains
|
Graphical View
of Protein Domain Structure
|
|
References
|
(Earliest)
J:7312
Bubbers JE,
"Identification and linkage analyses of a gene, Rcs-1, suppressing spontaneous SJL/J lymphoma expression."
J Natl Cancer Inst 1984 Feb;72(2):441-6
(Latest)
J:155241
Roundy KM et al.,
"Deletion of putative intronic control sequences does not alter cell or stage specific expression of Cr2."
Mol Immunol 2009 Dec;47(2-3):517-25
|
All references(110)
|
Other
accession IDs
|
MGD-MRK-2122, MGD-MRK-2123, MGD-MRK-2124, MGD-MRK-2125
|
Analysis Tools
MGI BioMart
